The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EXELIXIS INC | COM | 30161Q104 | 343,589 | 15,966,038 | SH | SOLE | 15,966,038 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 42,421 | 1,030,639 | SH | SOLE | 1,030,639 | 0 | 0 | ||
| CELLDEX THERAPEUTICS | COM | 15117B103 | 3,179 | 6,312,700 | SH | SOLE | 6,312,700 | 0 | 0 | ||
| WISDOMTREE INDIA EARNINGS FUND | COM | 97717W422 | 10,068 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ISHARES MSCI INDIA ETF | COM | 46429B598 | 9,654 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC | COM | 29664W105 | 103,063 | 2,629,835 | SH | SOLE | 2,629,835 | 0 | 0 | ||